nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—HTR2A—conduct disorder	0.876	1	CbGaD
Flupentixol—DDC—Amine-derived hormones—CGA—conduct disorder	0.0123	0.104	CbGpPWpGaD
Flupentixol—DRD1—Dopamine receptors—DRD4—conduct disorder	0.00912	0.0773	CbGpPWpGaD
Flupentixol—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00688	0.0583	CbGpPWpGaD
Flupentixol—DDC—Dopamine metabolism—COMT—conduct disorder	0.00655	0.0555	CbGpPWpGaD
Flupentixol—DDC—Dopamine metabolism—MAOA—conduct disorder	0.00651	0.0552	CbGpPWpGaD
Flupentixol—DDC—Biogenic Amine Synthesis—COMT—conduct disorder	0.00584	0.0495	CbGpPWpGaD
Flupentixol—DDC—Biogenic Amine Synthesis—MAOA—conduct disorder	0.0058	0.0492	CbGpPWpGaD
Flupentixol—DDC—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00554	0.047	CbGpPWpGaD
Flupentixol—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00218	0.0185	CbGpPWpGaD
Flupentixol—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00206	0.0175	CbGpPWpGaD
Flupentixol—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.00201	0.0171	CbGpPWpGaD
Flupentixol—DDC—Amino acid and derivative metabolism—CGA—conduct disorder	0.00171	0.0145	CbGpPWpGaD
Flupentixol—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00169	0.0144	CbGpPWpGaD
Flupentixol—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00156	0.0132	CbGpPWpGaD
Flupentixol—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00152	0.0129	CbGpPWpGaD
Flupentixol—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.0015	0.0127	CbGpPWpGaD
Flupentixol—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.00149	0.0126	CbGpPWpGaD
Flupentixol—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.00147	0.0124	CbGpPWpGaD
Flupentixol—Quetiapine—DRD4—conduct disorder	0.00138	0.223	CrCbGaD
Flupentixol—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.00131	0.0111	CbGpPWpGaD
Flupentixol—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00128	0.0108	CbGpPWpGaD
Flupentixol—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00126	0.0107	CbGpPWpGaD
Flupentixol—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00125	0.0106	CbGpPWpGaD
Flupentixol—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.00125	0.0106	CbGpPWpGaD
Flupentixol—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00123	0.0104	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00118	0.01	CbGpPWpGaD
Flupentixol—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0011	0.00937	CbGpPWpGaD
Flupentixol—Zuclopenthixol—HTR2A—conduct disorder	0.0011	0.178	CrCbGaD
Flupentixol—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000992	0.00841	CbGpPWpGaD
Flupentixol—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.000971	0.00823	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—SLC6A4—conduct disorder	0.000967	0.0082	CbGpPWpGaD
Flupentixol—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000956	0.0081	CbGpPWpGaD
Flupentixol—Thiothixene—HTR2A—conduct disorder	0.00095	0.153	CrCbGaD
Flupentixol—DDC—Circadian rythm related genes—DRD4—conduct disorder	0.000909	0.00771	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000891	0.00756	CbGpPWpGaD
Flupentixol—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000834	0.00707	CbGpPWpGaD
Flupentixol—Fluphenazine—HTR2A—conduct disorder	0.000821	0.133	CrCbGaD
Flupentixol—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000816	0.00692	CbGpPWpGaD
Flupentixol—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000804	0.00681	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000727	0.00616	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000665	0.00564	CbGpPWpGaD
Flupentixol—Trifluoperazine—HTR2A—conduct disorder	0.000656	0.106	CrCbGaD
Flupentixol—Perphenazine—HTR2A—conduct disorder	0.000649	0.105	CrCbGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000638	0.00541	CbGpPWpGaD
Flupentixol—Quetiapine—HTR2A—conduct disorder	0.000637	0.103	CrCbGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000595	0.00504	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000505	0.00428	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000475	0.00402	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000459	0.00389	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000453	0.00384	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000449	0.00381	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000442	0.00375	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000439	0.00373	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000433	0.00367	CbGpPWpGaD
Flupentixol—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000389	0.0033	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000385	0.00326	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000381	0.00323	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000373	0.00316	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000358	0.00304	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.000351	0.00297	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000346	0.00293	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000342	0.0029	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000336	0.00285	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.000335	0.00284	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000333	0.00282	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000329	0.00279	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000316	0.00268	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CGA—conduct disorder	0.000315	0.00267	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—EP300—conduct disorder	0.000314	0.00266	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000294	0.00249	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000289	0.00245	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000287	0.00244	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000283	0.0024	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000256	0.00217	CbGpPWpGaD
Flupentixol—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000254	0.00215	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000254	0.00215	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000251	0.00213	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000247	0.0021	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000246	0.00209	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000242	0.00206	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000242	0.00205	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000239	0.00202	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000232	0.00197	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000217	0.00184	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000217	0.00184	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000213	0.00181	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000193	0.00164	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000192	0.00162	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000192	0.00162	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.00019	0.00161	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000189	0.0016	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000188	0.0016	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000187	0.00159	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000187	0.00159	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000187	0.00158	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000186	0.00158	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000185	0.00156	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000185	0.00156	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000175	0.00149	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000173	0.00146	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.000172	0.00146	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000169	0.00143	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.000165	0.0014	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000164	0.00139	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000164	0.00139	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000161	0.00136	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000158	0.00134	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000154	0.0013	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000149	0.00127	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.000143	0.00122	CbGpPWpGaD
Flupentixol—DDC—Metabolism—COMT—conduct disorder	0.000142	0.0012	CbGpPWpGaD
Flupentixol—DDC—Metabolism—MAOA—conduct disorder	0.000141	0.0012	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CGA—conduct disorder	0.000137	0.00116	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.00013	0.0011	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000125	0.00106	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000124	0.00105	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.000122	0.00104	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.000121	0.00103	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00012	0.00102	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—WASF1—conduct disorder	0.00011	0.000933	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000108	0.000917	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	0.000106	0.000903	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.000106	0.000898	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000104	0.000884	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CGA—conduct disorder	0.000104	0.000879	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CGA—conduct disorder	0.000102	0.000865	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CGA—conduct disorder	0.000101	0.00086	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CGA—conduct disorder	9.99e-05	0.000847	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—DRD4—conduct disorder	9.83e-05	0.000833	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—DRD4—conduct disorder	9.67e-05	0.00082	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—DRD4—conduct disorder	9.62e-05	0.000815	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	9.47e-05	0.000803	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	9.35e-05	0.000793	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HTR2A—conduct disorder	8.49e-05	0.00072	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—WASF1—conduct disorder	8.31e-05	0.000704	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—WASF1—conduct disorder	8.17e-05	0.000693	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—WASF1—conduct disorder	8.13e-05	0.000689	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—WASF1—conduct disorder	8e-05	0.000679	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	7.99e-05	0.000677	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—DRD4—conduct disorder	7.69e-05	0.000652	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CGA—conduct disorder	7.67e-05	0.000651	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	7.06e-05	0.000599	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	6.91e-05	0.000586	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	6.8e-05	0.000577	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HTR2A—conduct disorder	6.41e-05	0.000544	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	6.28e-05	0.000532	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	6.18e-05	0.000524	CbGpPWpGaD
Flupentixol—DDC—Metabolism—EP300—conduct disorder	6.09e-05	0.000516	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—DRD4—conduct disorder	5.81e-05	0.000492	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—DRD4—conduct disorder	5.71e-05	0.000484	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—DRD4—conduct disorder	5.68e-05	0.000482	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—DRD4—conduct disorder	5.59e-05	0.000474	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HTR2A—conduct disorder	5.02e-05	0.000425	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.79e-05	0.000321	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HTR2A—conduct disorder	3.71e-05	0.000314	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	3.65e-05	0.000309	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—COMT—conduct disorder	3.46e-05	0.000294	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—MAOA—conduct disorder	3.44e-05	0.000292	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EP300—conduct disorder	2.66e-05	0.000225	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EP300—conduct disorder	2.01e-05	0.00017	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EP300—conduct disorder	1.97e-05	0.000167	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EP300—conduct disorder	1.96e-05	0.000166	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.93e-05	0.000164	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—EP300—conduct disorder	1.49e-05	0.000126	CbGpPWpGaD
